Press

Kardium completes first commercial procedures with the Globe Mapping and Ablation System

September 11, 2020

Early successes in roll-out of world’s most complete solution for atrial fibrillation

Read More

Commercialization prospects appear fruitful for BC’s Kardium even amid pandemic (Business in Vancouver)

June 30, 2020

Medical device company gets certification for European sales.

Read More

Kardium® announces successful results from the GLOBAL-AF study (Financial Post)

October 8, 2019

Global-AF study demonstrated a 76% percent freedom from atrial fibrillation at 12 months after a single treatment with the Globe System.

Read More

Kardium Announces New Financing to Commercialize the Globe System for the Treatment of Atrial Fibrillation (Cardiac Vascular News)

February 7, 2019

Financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from other new and existing Kardium shareholders.

Read More

Kardium seeking CE Mark for breakthrough treatment of atrial fibrillation (BioTuesdays)

June 26, 2018

Kardium hopes to receive marketing approval in Europe and launch its breakthrough Globe Mapping and Ablation System.

Read More

First Human Cases Treated With Globe Multi-electrode Contact Mapping and Ablation System (Diagnostic and Interventional Cardiology – DAIC)

May 21, 2018

Study at Heart Rhythm 2018 shows very good efficacy in treating atrial fibrillation.

Read More

European fortunes in forecast for B.C. pharma (Business in Vancouver)

April 26, 2018

Burnaby-based medical technology maker Kardium Inc. is launching a device to treat atrial fibrillation in Europe.

Read More

Long road to commercialization about to pay off for B.C.’s Kardium (Business in Vancouver)

March 7, 2018

Medical-tech firm’s device speeds up analysis, treatment of heart condition.

Read More

My Engineering Co-ops: Lungpacer Medical Inc. & Kardium

October 7, 2015

SFU student Jose Mendoza discovered his career direction as a result of his co-op experience at Kardium.

Read More